[Molecular diagnosis of HPV infections]
- PMID: 21845360
- PMCID: PMC4237608
- DOI: 10.1007/s00292-011-1475-6
[Molecular diagnosis of HPV infections]
Abstract
Carcinogenic human papillomaviruses (HPV) cause the majority of cervical cancers and other anogentical cancers. Large randomized trials have shown that HPV testing can be efficiently used for primary cervical cancer screening. Other applications include the triage of abnormal cytology results and the follow-up of women after treatment. Many assays have been developed to measure DNA, RNA, and proteins of HPV. The various tests can have very different applications. It is important to validate HPV assays before they are implemented in screening or clinical care.
Figures


Comment in
-
[HPV-induced diseases of the female genital tract].Pathologe. 2011 Nov;32(6):449-50. doi: 10.1007/s00292-011-1473-8. Pathologe. 2011. PMID: 22038131 German. No abstract available.
References
-
- Burger EA, Kornor H, Klemp M, Lauvrak V, Kristiansen IS. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol. 2011;120:430–8. - PubMed
-
- Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El GF. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204. - PubMed